Table 4.
Association between metabolic syndrome (MetS) diagnosis and hospital discharge to a skilled nursing facility as compared to regular discharge of patients with cancer, Nationwide Inpatient Sample, 2007–2011
| Cancer type | |||
|---|---|---|---|
|
| |||
| Breast cancer AOR (95%CI) | Colorectal cancer AOR (95%CI) | Prostate cancer AOR (95%CI) | |
| MetS diagnosis | |||
| No | Ref | Ref | Ref |
| Yes | 1.21(1.11–1.32) | 1.06(1.01–1.11) | 1.10(0.98–1.23) |
| Age groups | |||
| ≧ 40 < 50 | Ref | Ref | Ref |
| ≧ 50 < 60 | 1.15(1.08–1.23) | 1.12(1.05–1.19) | 1.03(0.86–1.22) |
| ≧ 60 < 70 | 1.32(1.23–1.42) | 1.20(1.13–1.27) | 1.12(0.94–1.33) |
| ≧ 70 | 2.38(2.20–2.58) | 2.51(2.36–2.68) | 2.60(2.17–3.11) |
| Gender | |||
| Males | - | Ref | - |
| Females | - | 1.23(1.20–1.27) | - |
| Race | |||
| Whites | Ref | Ref | Ref |
| Blacks | 1.05(0.98–1.12) | 0.81(0.77–0.84) | 1.27(1.18–1.38) |
| Hispanics | 0.98(0.90–1.07) | 0.71(0.67–0.75) | 0.81(0.72–0.92) |
| Others | 0.80(0.73–0.89) | 0.76(0.71–0.81) | 0.79(0.68–0.91) |
| Region | |||
| Large metro | Ref | Ref | Ref |
| Small metro | 0.71(0.67–0.75) | 0.87(0.84–0.90) | 0.78(0.73–0.83) |
| Micropolitan | 0.71(0.66–0.77) | 0.92(0.88–0.96) | 0.69(0.62–0.76) |
| Not metro or micro | 0.57(0.52–0.62) | 0.83(0.79–0.87) | 0.78(0.70–0.86) |
| Area-level income | |||
| Q4-highest | Ref | Ref | Ref |
| Q3 | 0.93(0.88–0.99) | 1.01(0.97–1.05) | 1.09(1.01–1.18) |
| Q2 | 1.02(0.96–1.09) | 0.98(0.94–1.02) | 1.19(1.09–1.29) |
| Q1-lowest | 0.95(0.89–1.02) | 1.02(0.97–1.07) | 1.13(1.03–1.23) |
| Insurance | |||
| Private | Ref | Ref | Ref |
| Medicaid | 1.01(0.93–1.10) | 1.08(1.02–1.15) | 1.81(1.54–2.12) |
| Medicare | 1.67(1.57–1.78) | 1.51(1.44–1.57) | 1.54(1.43–1.66) |
| Other | 0.55(0.49–0.63) | 0.53(0.50–0.57) | 0.71(0.60–0.83) |
| # Comorbiditiesa | 1.22(1.17–1.27) | 1.25(1.23–1.28) | 1.35(1.29–1.41) |
| Metastasis | |||
| Non-metastatic/in situ | Ref | Ref | Ref |
| Metastatic | 1.43(1.37–1.50) | 1.13(1.10–1.16) | 2.02(1.86–2.19) |
| Cancer surgery* | |||
| No | Ref | Ref | - |
| Yes | 1.52(1.46–1.59) | 0.56(0.54–0.57) | - |
| Complications | |||
| No | Ref | Ref | Ref |
| Yes | 1.16(1.05–1.27) | 1.28(1.24–1.33) | 0.96(0.87–1.07) |
| Length of stay | 1.16(1.15–1.17) | 1.17(1.17–1.18) | 1.26(1.25–1.27) |
a
Comorbidities assessed based on ICD9 codes for the following: myocardial infarction, chronic heart failure, peripheral vascular disease, cerebrovascular disease, dementia, cardio-pulmonary disease, rheumatic disease, peptic ulcer disease, mild liver disease, hemiplegia, paraplegia, renal disease, liver disease, and HIV/AIDS
*
Cancer-specific surgeries